Aardvark Therapeutics completes IPO; issues 5.888M shares at $16.00, raises $94.2M gross

Aardvark Therapeutics, Inc.

IPO of 5,888,000 shares at $16.00 per share completed on Feb 14, 2025.
Gross proceeds $94.2M before underwriting discounts and commissions.
Amended certificate authorizes 490M common shares and 10M preferred shares.
Amended bylaws establish classified board, stockholder proposal procedures, and exclusive forum provision.
Common stock trades on Nasdaq under ticker AARD.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.